Talk to your doctor about RITUXAN HYCELA.
Important Safety Information (cont’d)
Additional Important Safety Information
Before receiving RITUXAN HYCELA, tell your healthcare provider about all of your medical conditions, including
ê Have had a severe reaction to a rituximab product or RITUXAN HYCELA
ê Have had a recent vaccination or are scheduled to receive vaccinations. You should not receive certain vaccines
before or during treatment with RITUXAN HYCELA
ê Are pregnant, plan to become pregnant, are breastfeeding, or plan to breastfeed. Talk to your healthcare provider
about the risks to your unborn baby if you receive RITUXAN HYCELA during pregnancy. Females who are able to
become pregnant should use effective birth control (contraception) during treatment with RITUXAN HYCELA and
for 12 months after the last dose of RITUXAN HYCELA. Talk to your healthcare provider about effective birth
control. It is not known if RITUXAN HYCELA passes into your breast milk. Do not breastfeed during treatment and
for at least 6 months after your last dose of RITUXAN HYCELA
These are not all of the possible side effects with RITUXAN HYCELA. Call your doctor for medical advice about
Please see additional Important Safety Information throughout as well as the accompanying Medication Guide.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side
effects to Genentech at (888) 835- 2555.
© 2018 Genentech USA, Inc. and Biogen. All rights reserved. RSC/032818/0027 Printed in USA. April 2018
Jointly Marketed by: Biogen and Genentech USA, Inc. RITUXAN HYCELA® is a registered trademark of Biogen.